© 2020 MJH Life Sciences and OncLive. All rights reserved.
October 19, 2019
Gary J. Schiller, MD, discusses the heterogeneity of acute myeloid leukemia.
October 17, 2019
Gary J. Schiller, MD, discusses the benefits and challenges of using venetoclax and glasdegib in patients with relapsed/refractory acute myeloid leukemia.
August 23, 2019
Gary J. Schiller, MD, director, Bone Marrow/Stem Cell Transplantation and professor of hematology/oncology, David Geffen School of Medicine, UCLA, underscores the importance of genomic testing in acute myeloid leukemia.